U.S. Physical Therapy: Copeland reports 6.3% stake

Copeland's reported 6.3% position includes separate voting and disposition authority figures for USPH common stock.

Rhea-AI Filing Summary

U S Physical Therapy Inc. (USPH) is the issuer in a Schedule 13G reporting that Copeland Capital Management, LLC beneficially owned 940,528 common shares, or 6.3% of the class, as of September 30, 2026. The report lists sole voting power over 612,654 shares and shared voting power over 150,697 shares; it lists shared dispositive power over 763,351 shares and sole dispositive power over zero shares.

Key Figures

Beneficial ownership: 940,528 shares Percent of class: 6.3% Sole voting power: 612,654 shares +3 more

6 metrics

Beneficial ownership 940,528 shares As of September 30, 2026

Percent of class 6.3% As of September 30, 2026

Sole voting power 612,654 shares Reported ownership

Shared voting power 150,697 shares Reported ownership

Shared dispositive power 763,351 shares Reported ownership

Sole dispositive power 0 shares Reported ownership

Key Terms

beneficially owned, sole power to vote or to direct the vote, shared power to vote or to direct the vote, shared power to dispose or to direct the disposition of

4 terms

beneficially owned financial

"Amount beneficially owned: 940,528"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole power to vote or to direct the vote financial

"Sole power to vote or to direct the vote: 612,654"

shared power to vote or to direct the vote financial

"Shared power to vote or to direct the vote: 150,697"

shared power to dispose or to direct the disposition of financial

"Shared power to dispose or to direct the disposition of: 763,351"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many USPH shares does Copeland Capital Management beneficially own?

Copeland Capital Management, LLC reported beneficial ownership of 940,528 USPH common shares, equal to 6.3% of the class, as of September 30, 2026.

What voting and dispositive power does Copeland report over USPH shares?

For the September 30, 2026 ownership report, Copeland lists sole voting power over 612,654 shares and shared voting power over 150,697 shares. It lists shared dispositive power over 763,351 shares and sole dispositive power over zero shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 03:06 PM EDT Accepted by SEC EDGAR 10/13/2026 - 03:05 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

U S PHYSICAL THERAPY INC /NV

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

90337L108

(CUSIP Number)

09/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 90337L108

1

Names of Reporting Persons

Copeland Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 612,654.00
6	Shared Voting Power 150,697.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 763,351.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

940,528.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.3 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: U S PHYSICAL THERAPY INC /NV
(b)	Address of issuer's principal executive offices: 1300 West Sam Houston Parkway South, Suite 300, Houston, Texas 77042
Item 2.
(a)	Name of person filing: Copeland Capital Management, LLC
(b)	Address or principal business office or, if none, residence: 161 Washington Street, Suite 1325, Conshohocken, Pennsylvania 19428
(c)	Citizenship: State of Delaware, United States
(d)	Title of class of securities: Common Stock, par value $0.01 per share
(e)	CUSIP Number(s): 90337L108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 940,528
(b)	Percent of class: 6.3 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 612,654
	(ii) Shared power to vote or to direct the vote: 150,697
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 763,351
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to U.S. Physical Therapy, Inc. is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Copeland Capital Management, LLC

Signature:	/s/ Sofia A. Rosala
Name/Title:	General Counsel and Chief Compliance Officer
Date:	10/13/2026